Hemolytic-uremic syndrome causes: Difference between revisions
Line 66: | Line 66: | ||
| doi = 10.1016/S0140-6736(17)30062-4 | | doi = 10.1016/S0140-6736(17)30062-4 | ||
| pmid = 28242109 | | pmid = 28242109 | ||
}}</ref><ref name="Lopes da Silva2011">{{cite journal|last1=Lopes da Silva|first1=Rodrigo|title=Viral-associated thrombotic microangiopathies|journal=Hematology/Oncology and Stem Cell Therapy|volume=4|issue=2|year=2011|pages=51–59|issn=16583876|doi=10.5144/1658-3876.2011.51}}</ref> | }}</ref><ref name="Lopes da Silva2011">{{cite journal|last1=Lopes da Silva|first1=Rodrigo|title=Viral-associated thrombotic microangiopathies|journal=Hematology/Oncology and Stem Cell Therapy|volume=4|issue=2|year=2011|pages=51–59|issn=16583876|doi=10.5144/1658-3876.2011.51}}</ref><ref>{{Cite journal | ||
| author = [[P. J. Medina]], [[J. M. Sipols]] & [[J. N. George]] | |||
| title = Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome | |||
| journal = [[Current opinion in hematology]] | |||
| volume = 8 | |||
| issue = 5 | |||
| pages = 286–293 | |||
| year = 2001 | |||
| month = September | |||
| pmid = 11604563 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[Fadi Fakhouri]], [[Lubka Roumenina]], [[Francois Provot]], [[Marion Sallee]], [[Sophie Caillard]], [[Lionel Couzi]], [[Marie Essig]], [[David Ribes]], [[Marie-Agnes Dragon-Durey]], [[Frank Bridoux]], [[Eric Rondeau]] & [[Veronique Fremeaux-Bacchi]] | |||
| title = Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations | |||
| journal = [[Journal of the American Society of Nephrology : JASN]] | |||
| volume = 21 | |||
| issue = 5 | |||
| pages = 859–867 | |||
| year = 2010 | |||
| month = May | |||
| doi = 10.1681/ASN.2009070706 | |||
| pmid = 20203157 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[Christine Skerka]], [[Mihaly Jozsi]], [[Peter F. Zipfel]], [[Marie-Agnes Dragon-Durey]] & [[Veronique Fremeaux-Bacchi]] | |||
| title = Autoantibodies in haemolytic uraemic syndrome (HUS) | |||
| journal = [[Thrombosis and haemostasis]] | |||
| volume = 101 | |||
| issue = 2 | |||
| pages = 227–232 | |||
| year = 2009 | |||
| month = February | |||
| pmid = 19190803 | |||
}}</ref> | |||
*E. coli (70%) | *E. coli (70%) | ||
* | *genetic mutations of complement genes | ||
*[Cause3] | *[Cause3] | ||
Line 76: | Line 107: | ||
*HUS is caused by an infection with National Shiga toxin-producing Escherichia(STEC), Streptococcus pneumoniae, viral infection, | *HUS is caused by an infection with National Shiga toxin-producing Escherichia(STEC), Streptococcus pneumoniae, viral infection, drug toxicity, | ||
-Human immunodeficiency viral infection. | -Human immunodeficiency viral infection. |
Revision as of 15:58, 7 August 2018
Hemolytic-uremic syndrome Microchapters |
Differentiating Hemolytic-uremic syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hemolytic-uremic syndrome causes On the Web |
American Roentgen Ray Society Images of Hemolytic-uremic syndrome causes |
Risk calculators and risk factors for Hemolytic-uremic syndrome causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
HUS can occur in the course of systemic diseases or physiopathological conditions such as pregnancy, after transplantation or after drug assumption. The major cause of HUS in childhood is infection with verocytotoxin (shiga-like toxin)-producing bacteria, usually enterohemorrhagic Escherichia coli (VTEC/STEC),and in some tropical regions Shigella dysenteriae type I. Verocytotoxin-producing Citrobacter freundii, has also been reported.8 In America and the UK most cases are associated with E. coli serotype O157:H7,9–12 while other serotypes such as O26, O111, O103, and O145 are increasingly reported in Europe and elsewhere.13–15 The epidemiology has been extensively studied. Patients are usually pre-school children.16–18 VTEC strains produce various toxins, the major ones being verocytotoxin-1 (Stx1) and verocytotoxin-2 (Stx2). Verocytotoxin-1 differs by one amino acid from Shiga toxin produced by Shigella dysenteriae type 1. Verocytotoxin-2 has multiple variants that are closely related to each other, but have 55–60% homology to verocytotoxin1. HUS is mostly caused by verocytotoxin-2-producing strains*
Causes
Life-threatening Causes
- Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. There are no life-threatening causes of disease name, however complications resulting from untreated disease name is common.
- Life-threatening causes of [symptom/manifestation] include [cause1], [cause2], and [cause3].
- [Cause] is a life-threatening cause of [disease].
Common Causes
Common causes of [disease name] may include:[1][2][3][4][5][6][7]
- E. coli (70%)
- genetic mutations of complement genes
- [Cause3]
OR
- HUS is caused by an infection with National Shiga toxin-producing Escherichia(STEC), Streptococcus pneumoniae, viral infection, drug toxicity,
-Human immunodeficiency viral infection.
- [Pathogen name] is caused by [pathogen name].
Less Common Causes
Less common causes of [disease name] include:
- [Cause1]
- [Cause2]
- [Cause3]
Genetic Causes
- [Disease name] is caused by a mutation in the [gene name] gene.
Causes by Organ System
Cardiovascular | No underlying causes |
Chemical/Poisoning | No underlying causes |
Dental | No underlying causes |
Dermatologic | No underlying causes |
Drug Side Effect | No underlying causes |
Ear Nose Throat | No underlying causes |
Endocrine | No underlying causes |
Environmental | No underlying causes |
Gastroenterologic | No underlying causes |
Genetic | No underlying causes |
Hematologic | No underlying causes |
Iatrogenic | No underlying causes |
Infectious Disease | No underlying causes |
Musculoskeletal/Orthopedic | No underlying causes |
Neurologic | No underlying causes |
Nutritional/Metabolic | No underlying causes |
Obstetric/Gynecologic | No underlying causes |
Oncologic | No underlying causes |
Ophthalmologic | No underlying causes |
Overdose/Toxicity | No underlying causes |
Psychiatric | No underlying causes |
Pulmonary | No underlying causes |
Renal/Electrolyte | No underlying causes |
Rheumatology/Immunology/Allergy | No underlying causes |
Sexual | No underlying causes |
Trauma | No underlying causes |
Urologic | No underlying causes |
Miscellaneous | No underlying causes |
Causes in Alphabetical Order
List the causes of the disease in alphabetical order:
- Cause 1
- Cause 2
- Cause 3
- Cause 4
- Cause 5
- Cause 6
- Cause 7
- Cause 8
- Cause 9
- Cause 10
References
- ↑ Shannon E. Majowicz, Elaine Scallan, Andria Jones-Bitton, Jan M. Sargeant, Jackie Stapleton, Frederick J. Angulo, Derrick H. Yeung & Martyn D. Kirk (2014). "Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis". Foodborne pathogens and disease. 11 (6): 447–455. doi:10.1089/fpd.2013.1704. PMID 24750096. Unknown parameter
|month=
ignored (help) - ↑ Chantal Loirat, Fadi Fakhouri, Gema Ariceta, Nesrin Besbas, Martin Bitzan, Anna Bjerre, Rosanna Coppo, Francesco Emma, Sally Johnson, Diana Karpman, Daniel Landau, Craig B. Langman, Anne-Laure Lapeyraque, Christoph Licht, Carla Nester, Carmine Pecoraro, Magdalena Riedl, Nicole C. A. J. van de Kar, Johan Van de Walle, Marina Vivarelli & Veronique Fremeaux-Bacchi (2016). "An international consensus approach to the management of atypical hemolytic uremic syndrome in children". Pediatric nephrology (Berlin, Germany). 31 (1): 15–39. doi:10.1007/s00467-015-3076-8. PMID 25859752. Unknown parameter
|month=
ignored (help) - ↑ Fadi Fakhouri, Julien Zuber, Veronique Fremeaux-Bacchi & Chantal Loirat (2017). "Haemolytic uraemic syndrome". Lancet (London, England). 390 (10095): 681–696. doi:10.1016/S0140-6736(17)30062-4. PMID 28242109. Unknown parameter
|month=
ignored (help) - ↑ Lopes da Silva, Rodrigo (2011). "Viral-associated thrombotic microangiopathies". Hematology/Oncology and Stem Cell Therapy. 4 (2): 51–59. doi:10.5144/1658-3876.2011.51. ISSN 1658-3876.
- ↑ P. J. Medina, J. M. Sipols & J. N. George (2001). "Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome". Current opinion in hematology. 8 (5): 286–293. PMID 11604563. Unknown parameter
|month=
ignored (help) - ↑ Fadi Fakhouri, Lubka Roumenina, Francois Provot, Marion Sallee, Sophie Caillard, Lionel Couzi, Marie Essig, David Ribes, Marie-Agnes Dragon-Durey, Frank Bridoux, Eric Rondeau & Veronique Fremeaux-Bacchi (2010). "Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations". Journal of the American Society of Nephrology : JASN. 21 (5): 859–867. doi:10.1681/ASN.2009070706. PMID 20203157. Unknown parameter
|month=
ignored (help) - ↑ Christine Skerka, Mihaly Jozsi, Peter F. Zipfel, Marie-Agnes Dragon-Durey & Veronique Fremeaux-Bacchi (2009). "Autoantibodies in haemolytic uraemic syndrome (HUS)". Thrombosis and haemostasis. 101 (2): 227–232. PMID 19190803. Unknown parameter
|month=
ignored (help)